Biosimilar to Biosimilar Infliximab Switching in Real-world Patients with Inflammatory Arthritis Followed in the Danish DANBIO Registry: Switch from Originator Infliximab to CT-P13 and Then to GP1111

Hafsah Nabi; Bente Glintborg; Anne Gitte Loft; Oliver Hendricks; Jens Kristian Pedersen; Søren Andreas Just; Rabiah Ahmed; Kamilla Danebod; Heidi Munk; Ada Colic; Asta Linauskas; Dorte Vendelbo Jensen; Johnny Raun; Jolanta Grydehøj; Louise Brot Christensen; Natalia Manilo; Niels Lomborg; Salome Kristensen; Frank Mehnert; Niels Steen Krogh; Merete Hetland

Biosimilar to Biosimilar Infliximab Switching in Real-world Patients with Inflammatory Arthritis Followed in the Danish DANBIO Registry: Switch from Originator Infliximab to CT-P13 and Then to GP1111

Hafsah Nabi, Bente Glintborg, Anne Gitte Loft, Oliver Hendricks, Jens Kristian Pedersen, Søren Andreas Just, Rabiah Ahmed, Kamilla Danebod, Heidi Munk, Ada Colic, Asta Linauskas, Dorte Vendelbo Jensen, Johnny Raun, Jolanta Grydehøj, Louise Brot Christensen, Natalia Manilo, Niels Lomborg, Salome Kristensen, Frank Mehnert, Niels Steen KroghMerete Hetland

Research output: Contribution to conference without publisher/journal › Conference abstract for conference › Research › peer-review

Original language	English
Publication date	Sept 2021
Number of pages	3
Publication status	Published - Sept 2021
Event	ACR Convergence 2021 - Virtual Duration: 3 Nov 2021 → 9 Nov 2021

Conference

Conference	ACR Convergence 2021
Location	Virtual
Period	03/11/2021 → 09/11/2021

Bibliographical note

Abstract No. 0573

Access to Document

https://acrabstracts.org/abstract/biosimilar-to-biosimilar-infliximab-switching-in-real-world-patients-with-inflammatory-arthritis-followed-in-the-danish-danbio-registry-switch-from-originator-infliximab-to-ct-p13-and-then-to-gp1111/

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Nabi, H., Glintborg, B., Loft, A. G., Hendricks, O., Pedersen, J. K., Just, S. A., Ahmed, R., Danebod, K., Munk, H., Colic, A., Linauskas, A., Jensen, D. V., Raun, J., Grydehøj, J., Christensen, L. B., Manilo, N., Lomborg, N., Kristensen, S., Mehnert, F., ... Hetland, M. (2021). Biosimilar to Biosimilar Infliximab Switching in Real-world Patients with Inflammatory Arthritis Followed in the Danish DANBIO Registry: Switch from Originator Infliximab to CT-P13 and Then to GP1111. 1161-1163. Abstract from ACR Convergence 2021. https://acrabstracts.org/abstract/biosimilar-to-biosimilar-infliximab-switching-in-real-world-patients-with-inflammatory-arthritis-followed-in-the-danish-danbio-registry-switch-from-originator-infliximab-to-ct-p13-and-then-to-gp1111/

@conference{86fa0ebd89014285aedb2f52499902aa,

title = "Biosimilar to Biosimilar Infliximab Switching in Real-world Patients with Inflammatory Arthritis Followed in the Danish DANBIO Registry: Switch from Originator Infliximab to CT-P13 and Then to GP1111",

author = "Hafsah Nabi and Bente Glintborg and Loft, {Anne Gitte} and Oliver Hendricks and Pedersen, {Jens Kristian} and Just, {S{\o}ren Andreas} and Rabiah Ahmed and Kamilla Danebod and Heidi Munk and Ada Colic and Asta Linauskas and Jensen, {Dorte Vendelbo} and Johnny Raun and Jolanta Grydeh{\o}j and Christensen, {Louise Brot} and Natalia Manilo and Niels Lomborg and Salome Kristensen and Frank Mehnert and Krogh, {Niels Steen} and Merete Hetland",

note = "Abstract No. 0573; ACR Convergence 2021 ; Conference date: 03-11-2021 Through 09-11-2021",

year = "2021",

month = sep,

language = "English",

pages = "1161--1163",

}

Nabi, H, Glintborg, B, Loft, AG, Hendricks, O, Pedersen, JK, Just, SA, Ahmed, R, Danebod, K, Munk, H, Colic, A, Linauskas, A, Jensen, DV, Raun, J, Grydehøj, J, Christensen, LB, Manilo, N, Lomborg, N, Kristensen, S, Mehnert, F, Krogh, NS & Hetland, M 2021, 'Biosimilar to Biosimilar Infliximab Switching in Real-world Patients with Inflammatory Arthritis Followed in the Danish DANBIO Registry: Switch from Originator Infliximab to CT-P13 and Then to GP1111', ACR Convergence 2021, 03/11/2021 - 09/11/2021 pp. 1161-1163. <https://acrabstracts.org/abstract/biosimilar-to-biosimilar-infliximab-switching-in-real-world-patients-with-inflammatory-arthritis-followed-in-the-danish-danbio-registry-switch-from-originator-infliximab-to-ct-p13-and-then-to-gp1111/>

Biosimilar to Biosimilar Infliximab Switching in Real-world Patients with Inflammatory Arthritis Followed in the Danish DANBIO Registry: Switch from Originator Infliximab to CT-P13 and Then to GP1111. / Nabi, Hafsah; Glintborg, Bente; Loft, Anne Gitte et al.
2021. 1161-1163 Abstract from ACR Convergence 2021.

Research output: Contribution to conference without publisher/journal › Conference abstract for conference › Research › peer-review

TY - ABST

T1 - Biosimilar to Biosimilar Infliximab Switching in Real-world Patients with Inflammatory Arthritis Followed in the Danish DANBIO Registry: Switch from Originator Infliximab to CT-P13 and Then to GP1111

AU - Nabi, Hafsah

AU - Glintborg, Bente

AU - Loft, Anne Gitte

AU - Hendricks, Oliver

AU - Pedersen, Jens Kristian

AU - Just, Søren Andreas

AU - Ahmed, Rabiah

AU - Danebod, Kamilla

AU - Munk, Heidi

AU - Colic, Ada

AU - Linauskas, Asta

AU - Jensen, Dorte Vendelbo

AU - Raun, Johnny

AU - Grydehøj, Jolanta

AU - Christensen, Louise Brot

AU - Manilo, Natalia

AU - Lomborg, Niels

AU - Kristensen, Salome

AU - Mehnert, Frank

AU - Krogh, Niels Steen

AU - Hetland, Merete

N1 - Abstract No. 0573

PY - 2021/9

Y1 - 2021/9

M3 - Conference abstract for conference

SP - 1161

EP - 1163

T2 - ACR Convergence 2021

Y2 - 3 November 2021 through 9 November 2021

ER -